
Wilson Sonsini Goodrich & Rosati announced that Brent Snyder has joined the firm as a partner in the San Francisco office. He will be a member of the antitrust and competition practice.
With more than 25 years of civil and criminal litigation and trial experience in both the public and private sectors, Snyder is a leading US and internationally recognized antitrust and competition attorney with deep expertise in antitrust cartels.
Most recently, Snyder was CEO of the Hong Kong Competition Commission (HKCC), Hong Kong’s competition enforcement agency, from 2017 until 2020. In this role, he was responsible for all day-to-day operations, including enforcement, policy, competition advocacy, public outreach, and international cooperation. During his tenure, the HKCC set several important litigation precedents and significantly increased the volume, variety, and complexity of its enforcement work.
Previously, Snyder was the US Department of Justice’s highest-ranking criminal antitrust enforcement attorney. From 2003 to 2017, he focused on antitrust cartels and related criminal violations, starting as a trial attorney in the National Criminal Enforcement Section and then the San Francisco office of the DOJ’s Antitrust Division and continuing with his work as Deputy Assistant Attorney General for Criminal Enforcement (DAAG). As DAAG, he oversaw all Antitrust Division criminal investigations and prosecutions, as well as criminal policy matters. For instance, he oversaw the Automobile Parts, Foreign Exchange, Generic Drugs, Ocean Shipping, Packaged Seafood, and Real Estate Mortgage Foreclosure Auction investigations, which collectively resulted in dozens of corporate convictions, more than 100 individual convictions, and the imposition of several billion dollars in criminal fines. He also served as the Acting Assistant Attorney General for Antitrust during the transition between the Obama and Trump administrations.
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas